Viewing Study NCT02608359


Ignite Creation Date: 2025-12-24 @ 2:27 PM
Ignite Modification Date: 2026-02-20 @ 9:54 PM
Study NCT ID: NCT02608359
Status: WITHDRAWN
Last Update Posted: 2025-02-03
First Post: 2015-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer
Sponsor: Johnson & Johnson Private Limited
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR107096
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators